mozavaptan has been researched along with vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- in 1 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) | Trials (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) | Recent Studies (post-2010) (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 357 | 5 | 22 |
| Protein | Taxonomy | mozavaptan (IC50) | vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- (IC50) |
|---|---|---|---|
| Vasopressin V1a receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crofton, JT; Funyu, T; Liu, HW; Share, L; Wang, YX | 1 |
1 other study(ies) available for mozavaptan and vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-
| Article | Year |
|---|---|
Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Deamino Arginine Vasopressin; Drug Evaluation, Preclinical; Feedback; Female; Hormone Antagonists; Injections, Intraventricular; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sex Characteristics; Sodium Chloride; Vasopressins | 1996 |